Atuzabrutinib
Atuzabrutinib (SAR 444727) is a selective Bruton's tyrosine kinase (Btk) inhibitor that inhibits intra-neutrophilic neutrophilic granulocytes through inhibition of the adhesion receptor signaling pathway, and can be used to study autoimmune disorders such as arthritis in rheumatoid rodents and pemphigus vulgaris.
Product Specifications
CAS Number
1581714-49-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
539.6
Molecular Formula
C30H30FN7O2
Notes
Research use only, not for human use.
Receptor
BTK
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
245717-ML405 100 µL
EMX2 (Empty Spiracles Homeobox 2) (MaxLight 405) discontinued
Sign In for Pricing
View Details ABC-X2219 1 Vial
Xpress™ Human PAPOLB Over-expressing Stable Cell Line
Sign In for Pricing
View Details CAU34742-01 100 µL
Enolase, Neuron Specific (NSE) Monoclonal Antibody
Sign In for Pricing
View Details